NCT00004864View on ClinicalTrials.gov

Docetaxel and GEM 231 in Treating Patients With Recurrent or Refractory Solid Tumors

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 1999

Primary Completion Date

June 30, 2000

Study Completion Date

June 30, 2000

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

GEM 231

DRUG

docetaxel

Trial Locations (1)

10461

Albert Einstein Comprehensive Cancer Center, The Bronx

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Montefiore Medical Center

OTHER

NCT00004864 - Docetaxel and GEM 231 in Treating Patients With Recurrent or Refractory Solid Tumors | Biotech Hunter | Biotech Hunter